NanoZymeX secures €160K to advance lipid nanoparticle enzyme therapies for rare diseases
NanoZymeX secures €160K to advance lipid nanoparticle enzyme therapies for rare diseases Biotech startup NanoZymeX has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new platform for enzyme replacement therapy using lipid nanoparticles. Spun out of research at the University of Basel, the technology aims to improve therapies
